Community-Acquired Bacterial Pneumonia (CABP) Treatment Drugs; Used to Treat CABP Caused By Various Bacterial Species
Community-acquired bacterial pneumonia (CABP) treatment drugs are used to treat bacterial pneumonia (community-acquired) caused by various bacterial species, such as S. pneumoniae, Chlamydia Pneumoniae, Pneumoniae, Mycoplasma, Legionella spp., Haemophilus influenzae type b (Hib), and many others. S. pneumoniae is the most common cause of death in patients with community-acquired pneumonia. Bacterial pneumonia is a type of lung infection, and can cause breathing problems and other symptoms.
Many bacteria, viruses, and fungi can cause bacterial pneumonia. The most common symptom of pneumonia is a cough that produces sputum, but fever, chills, chest pain, and shortness of breath are also common. However, the prevalence of pneumonia differs both regionally and by age group affecting from children to adults. Community-acquired bacterial pneumonia Treatment is the most common acute respiratory illnesses among various infections triggering sepsis. Moreover, it is the most common infectious cause of illness and hospitalization, especially in the elderly.
Bacterial pneumonia is treated with antibiotic therapy, while viral pneumonia will usually get better on its own. In some cases, viral pneumonia can lead to a secondary bacterial pneumonia, doctor may prescribe antibiotic therapy. Healthy adults under 65 years of age with pneumonia are treated with a combination of amoxicillin and a macrolide like Zithromax (azithromycin) or sometimes a tetracycline like Vibramycin (doxycycline). The most common treatment for bacterial pneumonia is macrolide antibiotics.
If pneumonia is caused by a virus, antibiotics won’t work, but antiviral drugs or Non-steroidal anti-inflammatory drugs (NSAIDs) may be used. Therefore, with the increasing prevalence of CABP, the demand for community-acquired bacterial pneumonia (CABP) treatment drugs is also increasing with a rapid pace. CABP is one of the most fatal infectious diseases in terms of incidence, effect on quality of life, mortality, and impact on society. For example, it is one of the most common infectious diseases as well as one of the leading cause of death in Japan.